It has been reported that the number of free SH groups in the sera of rheumatoid arthritis (RA) patients is depressed.1 2 This depression is associated with the activity of the disease.2 Hall et al. 3 have shown in vitro that H202 formed during phagocytosis by granulocytes diminishes the amount of free SH groups. These authors propose that serum SH groups act as important extracellular scavengers of peroxides and are therefore helpful in protecting the surrounding tissues. However it is unlikely that H202 is formed in the intravascular compartment, whereas H202 would be expected in the synovial fluid of RA patients due to 
stimulated phagocytes. We were able to confirm these data (unpublished results). In RA patients without extra-articular lesions it is unlikely that circulating granulocytes are stimulated and so would not produce H202. In the synovial fluid H202 is to be expected due to phagocytosis. It therefore seemed reasonable to assume that the amount of SH (timol/g protein) would be lower in the synovial fluid than in the sera of RA patients. However, our data showed that there was no difference in SH groups (per g protein) in these two compartments. It is possible that this is due to a rapid exchange of proteins between the synovial fluid and serum. Another possibility is that the synovial fluid contains a factor(s) which protect(s) the proteins effectively.
Treatment of RA patients with penicillamine leads to an increase in the amount of erythrocyte GSH.6 7 Although the absolute amount of GSH is important, in order to maintain cellular functions and provide a barrier against peroxidative destruction, the capacity to reduce the formed GSSG is also very important. This reaction enables the cell to withstand stress longer than would otherwise be possible if GSH were not regenerated. We have shown that there is no difference in GSH content of erythrocytes from RA patients and controls. If alterations of GSH levels did have a role in the aetiology of RA, it is possible that the capacity to regenerate GSH during oxidative stress could be reduced. However, erythrocytes from controls and RA patients were equally effective in regenerating GSH when challenged with cumene hydroperoxide.
It is therefore unlikely that the increase in erythrocyte GSH, observed on administration of penicillamine, can explain the disease remissions. Furthermore it is not known, at least to our knowledge, what happens to the GSH level in erythrocytes from controls treated with penicillamine. 
